Medtech M&A Trends: CEOs Talk Growth Strategy

After two years of sluggish M&A activity, medtech analysts headed into 2024 predicting an uptick in M&A across the industry. Now, as the first half of the year comes to a close, let's take a look at our Medtech M&A Meter and gauge M&A interest based on the latest executive commentary from the key players.